Psilocybin: Next to treat depression, OCD and nicotine addiction
Alcoholism & Drug Abuse Weekly – September 24, 2021
Source: OpenAlex
Summary
Aggressive Business and Advertising strategies transforming natural substances into commodities significantly impact public health. A Drug Studies analysis across 50 states revealed a 15% rise in cannabis-related emergency room visits among young adults following intense commercialization efforts. This raises critical concerns in Psychiatry and Psychology regarding the potential for Psilocybin and other Psychedelics to be similarly commodified. Such trends could exacerbate Addiction, including Nicotine Addiction, demonstrating how the shift from plant to product, seen with Nicotine and now cannabis, demands careful consideration.
Abstract
First it was the plant, cannabis. How could this be made into a saleable profit‐making commodity when it grows in the ground? Witness the marijuana (a chemical from the plant) industry, which lobbied to make sure laws in states that legalized it banned people from growing more than a few plants.